HBeAg-negative chronic hepatitis patients should be monitored more strictly: A cross-sectional retrospective study on antiviral treatment-naive patients

摘要

AimTo investigate the prevalence and characteristics of hepatitis B e antigen (HBeAg) negative/treatment naive subjects with low hepatitis B virus (HBV) DNA levels (<10(4)copies/ml) and low alanine aminotransferase (ALT) levels (<2xupper limit of normal) in patients with HBV-related hepatocellular carcinoma (HCC).